Archived Medical News Stories

RSSArchived Drug Trial News Stories - June 2011

Date Title Comments Rating
2011-06-30 Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia 1 None
2011-06-30 Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture 0 5
2011-06-30 PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint 0 None
2011-06-30 Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial 0 None
2011-06-30 Novartis reports NVA237 Phase III trial results against COPD 0 None
2011-06-30 Conference examines lagging ethical guidelines in face of expanding clinical trials in developing countries 0 None
2011-06-30 Provectus presents additional data on PV-10 at two separate melanoma conferences 0 None
2011-06-29 Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing 0 None
2011-06-29 Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis 0 None
2011-06-29 Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET 0 None
2011-06-29 USPTO awards patent for key therapeutic ingredient in CNVN202 targeted molecular cancer therapy 0 None
2011-06-29 Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness 0 None
2011-06-29 Macrogenics' Protege Phase 3 clinical study of teplizumab in type 1 diabetes published in The Lancet 0 None
2011-06-29 Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema 0 None
2011-06-29 Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients 0 None
2011-06-29 FDA clears Nuvo's IND for Lidocaine Spray formulation 0 None
2011-06-28 Relypsa initiates dosing in RLY5016 Phase 2b trial for hyperkalemia in diabetic nephropathy and CKD patients 0 None
2011-06-28 FDA accepts Pfizer's filing for axitinib review for advanced renal cell carcinoma 0 None
2011-06-28 Enrollment commences in Palatin's bremelanotide Phase 2b trial for female sexual dysfunction 0 2
2011-06-28 BioLineRx initiates enrollment in BL-1020 Phase II/III trial against schizophrenia 0 None
2011-06-28 Pfizer to present PF-299 and crizotinib clinical trial data on ALK at WCLC 2011 0 None
2011-06-28 Ticagrelor drug with low-dose aspirin effective against acute coronary syndrome 0 None
2011-06-28 TrialNet presents Diamyd Phase II study results on type 1 diabetes at ADA 2011 0 None
2011-06-28 Yale University: Gabapentin clinical study on epilepsy may have been a 'seeding trial' 0 None
2011-06-28 ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint 0 None
2011-06-28 Researchers, policy experts to examine issue of declining enrollment in clinical trials 0 None
2011-06-28 Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website 0 None
2011-06-28 Microbix renegotiates key terms of Hunan influenza vaccine joint venture 0 None
2011-06-28 Circulation journal publishes Celladon's MYDICAR Phase 2 trial on advanced heart failure 0 None
2011-06-28 Positive preliminary results from Anacor's AN2728 Phase 2b trial on psoriasis 0 None
2011-06-27 New and effective diabetes drug seeking approval 0 5
2011-06-27 Nile completes dosing in Part B of cenderitide Phase I study for ADHF 0 None
2011-06-27 Cardium to purchase Transdel's business assets 0 None
2011-06-27 Positive top line data from Mimetogen MIM-D3 Phase II clinical trial for dry eye disease 0 None
2011-06-27 Teva concludes Site Initiation Visit for Israeli clinical center in CEL-SCI's Multikine Phase III clinical trial 6 5
2011-06-27 Genentech, FORMA enter structurally innovative agreement for small molecule cancer program 0 None
2011-06-27 EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease 0 None
2011-06-27 FDA responds to EpiCept Ceplene SPA 0 None
2011-06-27 Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD 0 None
2011-06-27 Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer 0 None
2011-06-27 Biota reports preliminary data from CS-8958 Phase III trial against influenza 0 None
2011-06-27 Positive results from Stealth's Bendavia Phase I renal impairment study 0 None
2011-06-27 Positive data from Lyxumia study on type 2 diabetes presented at ADA 2011 0 None
2011-06-27 New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011 0 3.8
2011-06-27 Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes 0 5
2011-06-27 New bardoxolone methyl Phase 2 trial data on kidney disease, diabetes presented at ERA-EDTA 2011 0 3.5
2011-06-27 Promising results from MGH's BCG Phase I trial on type I diabetes 1 None
2011-06-27 Diabetic patients can benefit from basal insulin analogs 0 None
2011-06-27 New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011 0 None
2011-06-24 PCIB reports main results of Amphinex Phase I/II study against multiple cancers 0 None
2011-06-24 InVasc commences INV-144 Phase IIa trial in chronic kidney disease 0 None
2011-06-24 Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's 0 None
2011-06-24 Nature News examines controversy surrounding Indian HPV vaccine trial 0 None
2011-06-24 Millennium reports ongoing MLN8237 Phase II study results on non-Hodgkin lymphoma 0 None
2011-06-24 Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011 0 None
2011-06-24 Oxytocin hormone holds promise for children with Prader-Willi syndrome 1 None
2011-06-24 Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS 0 1
2011-06-24 GeoVax opens third clinical trial site for testing HIV/AIDS vaccine 0 None
2011-06-24 Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer 0 None
2011-06-23 Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals 0 None
2011-06-23 FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency 0 None
2011-06-23 MAP to present LEVADEX data on migraine at 15th Congress of IHC 0 None
2011-06-23 Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures 0 None
2011-06-23 Monash researchers receive MMV Project of the Year award for new anti-malarial drug candidate 0 None
2011-06-23 Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes 0 None
2011-06-23 Telaprevir drug shows promise in curing hepatitis C infection 0 None
2011-06-22 Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection 0 None
2011-06-22 Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder 0 None
2011-06-22 Naurex commences GLYX-13 Phase II trial in treatment-resistant depression 0 None
2011-06-22 Multiple abstracts on QNEXA long-term clinical study to be presented at ADA 2011 0 None
2011-06-22 Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery 0 None
2011-06-22 Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD 0 None
2011-06-22 Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis 0 None
2011-06-22 Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C 0 None
2011-06-22 Pycnogenol, CoQ10 combination boost heart function 0 4
2011-06-22 Results of African malaria vaccine trial expected later this year 0 None
2011-06-22 CEL-SCI announces results from Multikine Phase II trial on head and neck cancer 0 None
2011-06-22 Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint 0 1
2011-06-21 Seaside Therapeutics commences STX209 Phase 2b study in autism spectrum disorders 0 None
2011-06-21 DIA recognizes CAPRISA team for outstanding achievement in HIV prevention 0 None
2011-06-21 Positive results from LCP-Tacro Phase III trial in stable kidney transplant recipients 0 None
2011-06-21 Lorcaserin Phase 3 trial data on type 2 diabetes to be presented at ADA 2011 0 5
2011-06-21 Halozyme to present three data on Ultrafast Insulin programs at ADA 2011 0 None
2011-06-21 Lilly, Boehringer Ingelheim to present new data from diabetes portfolio at ADA scientific sessions 0 None
2011-06-21 New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women 0 None
2011-06-21 Amylin to present data on investigational diabetes drug candidates at ADA annual meeting 0 None
2011-06-20 Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder 0 None
2011-06-20 Spectrum announces various clinical studies on ZEVALIN at ICML 2011 0 None
2011-06-20 Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity 0 5
2011-06-20 GTx commences Capesaris Phase IIb trial in advanced prostate cancer 0 None
2011-06-20 Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome 0 None
2011-06-20 Positive results from vismodegib Phase II study on advanced basal cell carcinoma 0 None
2011-06-20 Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011 0 None
2011-06-18 Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas 0 None
2011-06-17 Positive data from Ischemix CMX-2043 Phase 2a trial for peri-operative cardiac ischemia-reperfusion injury 0 None
2011-06-17 Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital 0 None
2011-06-17 Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL 0 None
2011-06-17 VIVUS Avanafil phase 3 trial on erectile dysfunction meets primary endpoints 0 None
2011-06-17 Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma 0 None
2011-06-17 REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference 0 None
2011-06-17 Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD 0 None
2011-06-17 CTI announces positive results from Phase I-II pixantrone combination study against INHL 0 None
2011-06-17 Experimental vaccine shows promise for patients with newly diagnosed brain tumors 0 None
2011-06-17 Positive results from etanercept pilot study against dermatomyositis 0 None
2011-06-17 BioClinica releases new Trident IWR solution 0 None
2011-06-16 New Australian drug shows positive response in patients with multiple myeloma blood cancer 3 2.4
2011-06-16 Adaptimmune melanoma trial opening 0 None
2011-06-16 Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis 0 None
2011-06-16 Enrollment complete in NeurogesX NGX-1998 Phase 2 clinical study for postherpetic neuralgia 0 None
2011-06-16 Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections 0 None
2011-06-16 Large trial of tenofovir gel for women set to begin in South Africa 0 None
2011-06-16 Positive results from BiondVax Multimeric-001 Phase IIa trial against influenza 0 None
2011-06-16 Boehringer Ingelheim, Zealand Pharma partner to develop Type-2 diabetes and obesity agonists 0 None
2011-06-16 Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011 0 None
2011-06-16 Positive results from SKP-1041 Phase 2 study in insomnia patients with MOTN awakenings 0 None
2011-06-16 Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences 0 None
2011-06-16 Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease 0 None
2011-06-15 Alkermes commences ALKS 5461 phase 1/2 study for treatment-resistant depression 0 None
2011-06-15 Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID 0 None
2011-06-15 Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer 0 None
2011-06-15 immatics initiates IMA901 Phase III trial in renal cell carcinoma 0 None
2011-06-15 Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011 0 None
2011-06-15 Sangart commences MP4OX Phase 2b study in acute traumatic injury 0 None
2011-06-15 Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen 0 None
2011-06-15 Positive results from Neurelis NRL-01 Phase 1 trial against epilepsy 0 None
2011-06-14 CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury 0 None
2011-06-14 The Lancet publishes final 3-year data from landmark HORIZONS-AMI clinical trial 0 None
2011-06-14 TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes 0 None
2011-06-14 New findings from Deplin clinical trial on major depressive disorder presented at NCDEU 1 5
2011-06-14 Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer 0 None
2011-06-14 GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE 0 None
2011-06-14 FDA approves Cornell Dots for first-in-human clinical trial for treatment of cancer 0 None
2011-06-14 Cinryze data on hereditary angioedema presented at EAACI 2011 0 None
2011-06-14 Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML 0 None
2011-06-13 Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia 0 None
2011-06-13 Study reveals positive impact of Soliris on long-term outcomes in PNH patients 1 5
2011-06-13 CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary 0 None
2011-06-13 Trimeris, Synageva enter definitive merger agreement 0 None
2011-06-13 Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma 0 None
2011-06-13 Circassia announces ToleroMune vaccine phase II trial results against cat allergy 0 None
2011-06-13 Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials 0 None
2011-06-13 Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis 0 3
2011-06-13 Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA 0 None
2011-06-13 Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011 0 4
2011-06-10 Preliminary results from Edison's EPI-A0001 28-day phase 2A trial against Friedreich's ataxia 0 5
2011-06-10 Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function 0 4
2011-06-10 Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011 0 None
2011-06-10 FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma 0 None
2011-06-10 Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting 0 None
2011-06-09 Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease 0 None
2011-06-09 Promising results from VX-770 and VX-809 Phase 2 study for cystic fibrosis 0 5
2011-06-09 ImmunoCellular expands ICT-107 Phase II clinical trial for glioblastoma multiforme 0 None
2011-06-09 Vertex announces interim results from VX-770 and VX-809 Phase 2 study on cystic fibrosis 0 None
2011-06-09 TD2, Imaging Endpoints team up to enable rapid development of anti-cancer drugs 0 None
2011-06-09 Patient enrollment complete in cilengitide Phase III study against glioblastoma 0 3
2011-06-09 Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease 0 None
2011-06-09 FDA accepts Adamis IND for APC-100 to treat prostate cancer 0 None
2011-06-08 Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO 0 None
2011-06-08 Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection 0 None
2011-06-08 New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA 0 None
2011-06-08 Pharmasset expands PSI-7977 clinical trial for treatment of chronic hepatitis C 0 None
2011-06-08 Millennium reports results from two VELCADE based combination studies against multiple myeloma 0 None
2011-06-08 Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates 0 None
2011-06-08 Vaccine candidate produces immune response to antigen in all strains of influenza A 0 None
2011-06-08 Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis 0 None
2011-06-08 Cabozantinib shows early promise in treatment of prostate cancer spread to the bone 0 None
2011-06-08 MSU professor to lead acetazolamide clinical trial on idiopathic intracranial hypertension 0 None
2011-06-08 MicroDose completes atropine inhaler Phase I study on nerve agent poisoning 0 None
2011-06-08 SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189 0 None
2011-06-08 Top-line results from Cipher's CIP-ISOTRETINOIN Phase III study against severe nodular acne 0 None
2011-06-08 Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS 0 None
2011-06-07 Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011 0 None
2011-06-07 LLS announces four new Academic Concierge partnerships for cancer drug development 0 None
2011-06-07 Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences 1 None
2011-06-07 NanoViricides' anti-influenza drug development studies to be presented at TechConnect World 2011 0 None
2011-06-07 ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011 0 None
2011-06-07 AMPYRA ER Tablets improve walking ability in patients with multiple sclerosis 0 2
2011-06-07 Unique clinical trial addresses important questions about treating AIDS-related cancers 0 None
2011-06-07 Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011 0 4
2011-06-07 Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting 0 4.3
2011-06-07 FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold 0 None
2011-06-07 Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 study 0 None
2011-06-07 Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma 0 None
2011-06-07 Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer 0 None
2011-06-07 Ridaforolimus Phase III SUCCEED clinical trial on metastatic sarcoma meets primary endpoint 0 None
2011-06-07 SPI to commence enrollment in SPI-1005 clinical trial to prevent hearing loss induced by loud music 0 None
2011-06-07 Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011 0 None
2011-06-07 Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011 0 None
2011-06-07 VentiRx presents VTX-2337 Phase 1 trial results against advanced solid tumors at ASCO 2011 0 None
2011-06-07 Crucell, GSK and PATH MVI partner to develop second-generation vaccine against malaria 0 None
2011-06-07 Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC 0 None
2011-06-07 Tragara's apricoxib-erlotinib Phase 2 study data on non-small cell lung cancer presented at ASCO 2011 0 None
2011-06-07 Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011 0 None
2011-06-07 Teva's lipegfilgrastim-pegfilgrastim comparative Phase III study in breast cancer meets primary endpoint 0 None
2011-06-07 Positive results from RXi NeuVax Phase 2 trial on breast cancer presented at ASCO 2011 0 4
2011-06-07 Positive results from Celator CPX-351 Phase 2b study on acute myeloid leukemia presented at ASCO 0 None
2011-06-06 Trifunctional antibody Catumaxomab triggers vaccination effect against cancer 0 None
2011-06-06 Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year 0 None
2011-06-06 Encouraging data from Cylene CX-4945 Phase I dose-escalation trial presented at ASCO 2011 0 None
2011-06-06 Onconova to initiate ESTYBON Phase II/III study in pancreatic cancer 0 1
2011-06-06 Astellas to present positive AGS-1C4D4 phase II data in metastatic pancreatic cancer at ASCO 2011 0 None
2011-06-06 Genesis Biopharma expands clinical focus to develop Contego for Stage IV metastatic melanoma 0 None
2011-06-06 Incyte seeks FDA marketing approval of ruxolitinib for myelofibrosis 0 None
2011-06-06 Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation 0 None
2011-06-06 Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011 0 None
2011-06-06 Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011 0 None
2011-06-06 Chiasma presents Octreolin pharmacology data from clinical studies at International Pituitary Congress 0 None
2011-06-06 GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patients with NSCLC 0 None
2011-06-06 United Therapeutics completes oral treprostinil Phase 3 trial on pulmonary arterial hypertension 0 None
2011-06-06 NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011 0 None
2011-06-06 Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC 0 None
2011-06-06 Positive interim results from CTI's OPAXIO-TMZ phase II trial on malignant brain tumors presented at ASCO 0 5
2011-06-06 Interim results from CTI, Chroma Therapeutics' tosedostat phase II trial on AML presented at ASCO 0 None
2011-06-06 New targeted therapy may halt tumor growth in men with advanced prostate cancer 0 None
2011-06-06 Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO 0 5
2011-06-06 Synta presents ganetespib Phase 2 trial results in advanced non-small cell lung cancer at ASCO 2011 0 None
2011-06-06 New data from Argos AGS-003, sunitinib Phase 2 combination study on RCC presented at ASCO 0 1
2011-06-06 Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint 0 None
2011-06-06 ImmunoGen's IMGN901 Phase I trial data on multiple myeloma presented at ASCO 2011 0 None
2011-06-06 Incyte's ruxolitinib Phase III trial data on myelofibrosis presented at ASCO 2011 0 None
2011-06-06 Women with breast cancer do not benefit from flaxseed 0 None
2011-06-06 Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint 0 None
2011-06-06 Ipsen decides to assess development of Irosustat in combination with hormonal therapies 0 None
2011-06-06 Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer 0 4
2011-06-06 ImmunoGen's SAR3419 Phase I trial data on B-cell non-Hodgkin's lymphoma presented at ASCO 2011 0 None
2011-06-06 Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011 0 None
2011-06-06 Exemestane reduces risk of breast cancer in high-risk, postmenopausal women 0 None
2011-06-06 Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma 0 None
2011-06-05 Ross River Fever vaccine trials begin 1 None
2011-06-04 Customizing targeted therapies to each tumor's molecular characteristics may effectively treat cancer 0 None
2011-06-04 Sanofi's semuloparin Phase III study data against venous thromboembolism presented at ASCO 2011 0 None
2011-06-04 Study links loss of PTEN gene with patient's response to melanoma therapy 0 None
2011-06-04 Impax announces results of IPX066 ADVANCE-PD and APEX-PD Phase III study against Parkinson's 0 None
2011-06-04 U of A researchers try to combat heart disease in cancer patients 0 None
2011-06-04 Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Menopause 0 5
2011-06-04 Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011 0 None
2011-06-04 Researcher to evaluate new approach for treatment of triple-negative breast cancer 0 None
2011-06-04 Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC 0 None
2011-06-04 Peptide vaccine, Interleukin-2 show promise for patients with metastatic melanoma 0 None
2011-06-04 Nano-formulated indomethacin at lower dose effective in treating pain 0 5
2011-06-04 EntreMed's ENMD-2076 Phase 2 trial data on platinum-resistant ovarian cancer presented at ASCO 2011 0 None
2011-06-04 Key findings from Phase I clinical trial of CPI-613 in AML to be presented at ASCO 2011 0 None
2011-06-04 YM reports updated interim results from CYT387 Phase I/II study on myelofibrosis 0 None
2011-06-04 Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma 0 None
2011-06-04 Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer 0 None
2011-06-04 Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma 0 None
2011-06-03 Cancer vaccine shows improved response rate in patients 0 None
2011-06-03 ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011 0 None
2011-06-03 ZYTIGA clinical study data on prostate cancer to be presented at ASCO 2011 0 None
2011-06-03 APC8015F investigational vaccine improves survival of prostate cancer patients 0 None
2011-06-03 Itraconazol may keep prostate cancer from worsening and delay need for chemotherapy in men 0 5
2011-06-03 Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis 0 None
2011-06-03 Angiotensin receptor blockers do not increase risk of cancer: FDA 0 None
2011-06-03 Positive interim results from iBio's H1N1 influenza subunit vaccine Phase 1 trial 0 None
2011-06-03 VCU Massey completes Bortezomib-Alvocidib Phase I clinical trial against blood cancers 0 None
2011-06-02 Seaside Therapeutics commences STX209 Phase 3 study in fragile X syndrome 0 None
2011-06-02 Final analysis of AVEO's tivozanib Phase 2 trial on kidney cancer patients presented at ASCO 2011 0 None
2011-06-02 Positive interim results from Fraunhofer USA CMB's HAC1 influenza vaccine Phase 1 trial 0 None
2011-06-02 AVEO’s ficlatuzumab-gefitinib Phase 1b/2 trial data against NSCLC to be presented at ASCO 2011 0 None
2011-06-02 Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting 0 None
2011-06-02 Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab 0 None
2011-06-02 Niiki Pharma to present NKP-1339 Phase I trial against metastatic cancer at ASCO 2011 0 5
2011-06-02 Anadys receives U.S. patent for setrobuvir to treat chronic hepatitis C 0 None
2011-06-02 Somnus Therapeutics completes SKP-1041 Phase 2 trial against sleep maintenance insomnia 0 None
2011-06-02 Fero Industries completes Sucanon human clinical trials on Type-2 diabetes 0 None
2011-06-01 Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma 0 None
2011-06-01 Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011 0 5
2011-06-01 Symphogen's Sym004 Phase 1 data on advanced solid tumors to be presented at ASCO 2011 0 None
2011-06-01 Diamyd European Phase III study in diabetes does not meet primary endpoint 0 None
2011-06-01 CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study 0 None
2011-06-01 Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease 0 None
2011-06-01 Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis 0 None


272 posts
72 raters